|
|
Additional
Resources
|
|
Will Osteoarthritis Spoil Your Golden Years?
By Steve Vaile
The most common form of arthritis affecting people today is osteoarthritis, also known as degenerative joint disease. It is estimated that over 20 million Americans are afflicted with Read more...
|
|
|
|
Arthritis
Glucosamine Relieves Arthritis Pain And Rehabilitates Cartilage Naturally
(ContentDesk) July 28, 2005 -- Glucosamine has been shown to rehabilitate cartilage reduce the progression of osteoarthritis and significantly lessen pain from arthritis. The best part is it's all natural.Arthritis affects 46.5% of all persons aged 65 and over (Fife, Bruce, The Detox Book, 1997, P. 30). is not a localized problem, but a metabolic or chemical dysfunction of the entire body. In order to get lasting relief from arthritis, the entire body must be put back into chemical balance (Fife, P. 82).Glucosamine is very beneficial in the treatment for and is backed by numerous double-blind, placebo-controlled studies. In these studies, glucosamine has been shown to rehabilitate cartilage reduce the progression of osteoarthritis and significantly lessen pain from arthritis. While glucosamine is believed to play a role in cartilage formation and repair, chondroitin gives cartilage its elasticity.Young Living offers glucosamine via its BLM capsules. BLM Capsules
Type II Collagen is an easily absorbed source of Glucosamine Sulfate, hyaluronic acid and chondroitin. These ingredients have been shown in numerous studies to support the body as it rebuilds cartilage and resupplies synovial fluid. Ingredients: Manganese, Potassium, Chloride, Proprietary blend of: Glucosamine Sulfate, Type II collagen, MSM, Idaho Balsam Fir, Wintergreen, Clove. Manganese (Ascorbate) assists your body with processing the glucosamine. This is a very important ingredient and one that is missing in nearly every glucosamine product on the market today.Another outstanding product receiving raving results in Regenolone. Regenolone is a pregnenolone cream that includes MSM and essential oils that combat pain, back pain, and other muscle and skeletal discomfort. MSM (Methylsulfonylmethane) is an exceptional source of nutritional sulfur – a mineral that is vital to protein synthesis and sound health. According to research compiled by Ronald Lawrence, Ph. D., M.D., and Stanley Jacob, M.D., MSM represents a safe, natural solution for chronic headaches, back pain, tendonitis, fibromyalgia, rheumatism, arthritis, athletic injuries, muscle spasms, asthma, and allergies..
We strive to provide only quality information, so
if
there is a specific topic related to arthritis
that you would
like us to cover, please contact us at any time.
And again, thank you to those contributing daily to
our Arthritis
Website, especially
regarding "treatment for arthritis".
Discounted
Arthritis Online Auction
If you can't find the
Arthritis information you are looking for please
try our Google
Search
Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Abbott<br/><b>Recruiting</b> - verified June 2010
Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
<b>Conditions</b>: Rheumatoid Arthritis; Insulin Resistance<br/><b>Intervention</b>: Drug: Hydroxychloroquine<br/><b>Sponsors</b>: Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)<br/><b>Not yet recruiting</b> - verified May 2010
Iyengar Yoga for Young People With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Behavioral: Iyengar Yoga<br/><b>Sponsor</b>: University of California, Los Angeles<br/><b>Recruiting</b> - verified March 2010
Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: adalimumab (Humira)<br/><b>Sponsor</b>: Abbott<br/><b>Completed</b> - verified August 2010
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Abbott; Institute of Political Economical & Social Researches, Greece<br/><b>Active, not recruiting</b> - verified July 2010
Effectiveness of Adalimumab on Extraarticular Manifestation in Patients With Active Rheumatoid Arthritis
<b>Conditions</b>: Active Rheumatoid Arthritis; Osteoporoses<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic<br/><b>Recruiting</b> - verified June 2010
Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: Collect of 10 ml of peripheric blood for DNA extraction<br/><b>Sponsor</b>: Centre Hospitalier Universitaire de Fort-de-France<br/><b>Enrolling by invitation</b> - verified April 2010
Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Dietary Supplement: Oncoxin + Viusid; Dietary Supplement: Placebo<br/><b>Sponsor</b>: Catalysis SL<br/><b>Recruiting</b> - verified November 2009
Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: Venous blood sample<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Recruiting</b> - verified October 2009
Targeting Synovitis in Early Rheumatoid Arthritis
<b>Conditions</b>: Rheumatoid Arthritis; Polyarthritis<br/><b>Interventions</b>: Other: Musculoskeletal Ultrasound; Other: 28 Joint Disease Activity Score<br/><b>Sponsors</b>: NHS Greater Glasgow and Clyde; University of Glasgow; Chief Scientist Office of the Scottish Government; Wyeth; Translational Medicine Research Collaboration<br/><b>Recruiting</b> - verified September 2009
Living Well With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Behavioral: Self-Help Group; Other: Education (Control) Group<br/><b>Sponsors</b>: Brigham and Women's Hospital; Bristol-Myers Squibb<br/><b>Recruiting</b> - verified May 2010
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Imperial College London; Merck<br/><b>Recruiting</b> - verified February 2010
Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Imperial College London; Medical Research Council<br/><b>Recruiting</b> - verified February 2010
Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
<b>Condition</b>: Active Rheumatoid Arthritis<br/><b>Intervention</b>: Drug: Etanercept<br/><b>Sponsor</b>: Wyeth<br/><b>Recruiting</b> - verified July 2009
A Study Comparing CRx-102 Plus Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Other: CRx-102 plus DMARD therapy; Other: Placebo plus DMARD therapy<br/><b>Sponsor</b>: CombinatoRx<br/><b>Completed</b> - verified September 2008
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: Tranilast; Drug: Placebo comparator<br/><b>Sponsors</b>: Imperial College London; Nuon Therapeutics, Inc.<br/><b>Withdrawn</b> - verified July 2009
RESTART C0168Z05 Rheumatoid Arthritis Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: Infliximab<br/><b>Sponsors</b>: Centocor Ortho Biotech Services, L.L.C.; Schering-Plough<br/><b>Completed</b> - verified July 2010
Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
<b>Conditions</b>: Rheumatoid Arthritis; Arthritis; Joint Diseases<br/><b>Intervention</b>: Drug: Adalimumab (Humira)<br/><b>Sponsors</b>: Hvidovre University Hospital; Abbott<br/><b>Completed</b> - verified June 2008
Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: Certolizumab pegol; Other: Placebo<br/><b>Sponsor</b>: UCB, Inc.<br/><b>Active, not recruiting</b> - verified June 2010
Study Evaluating Single Doses of SBI-087 in Subjects With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Drug: SBI-087<br/><b>Sponsors</b>: Wyeth; Trubion Pharmaceuticals<br/><b>Active, not recruiting</b> - verified July 2009
|
|
